Vera Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Vera Therapeutics stock have an average target of 63.13, with a low estimate of 26 and a high estimate of 100. The average target predicts an increase of 40.60% from the current stock price of 44.90.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$26	$63.13	$61	$100
Change	-42.09%	+40.60%	+35.86%	+122.72%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	3	3	4
Buy	5	4	4	4	4	3
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ritu Baral TD Cowen	TD Cowen	Strong Buy Maintains $60 → $73	Strong Buy	Maintains	$60 → $73	+62.58%	Dec 5, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $85 → $90	Strong Buy	Maintains	$85 → $90	+100.45%	Nov 10, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $53 → $52	Buy	Maintains	$53 → $52	+15.81%	Nov 7, 2025
Dina Ramadane B of A Securities	B of A Securities	Strong Buy Initiates $48	Strong Buy	Initiates	$48	+6.90%	Oct 16, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $56 → $53	Buy	Maintains	$56 → $53	+18.04%	Aug 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

35.19M

EPS This Year

-4.69

from -2.75

EPS Next Year

-4.87

from -4.69

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	35.19M
Revenue Growth	-	-	-	-	-	-	-
EPS	-166.93	-2.43	-3.35	-2.25	-2.75	-4.69	-4.87
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	66.7M
Avg	n/a	35.2M
Low	n/a	2.5M

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-4.60	-3.34
Avg	-4.69	-4.87
Low	-5.17	-6.29

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.